AbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025?Zacks Investment Research • 10/09/25
SkinMedica® Debuts Reimagined Packaging and Unveils New HA5® Hydra Collagen Water Burst MoisturizerPRNewsWire • 10/09/25
AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week?Zacks Investment Research • 10/06/25
AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX®) for the Treatment of Upper Limb Essential TremorPRNewsWire • 10/06/25
AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.PRNewsWire • 09/30/25
AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment OptionsPRNewsWire • 09/30/25
AbbVie Breaks Ground on New North Chicago Active Pharmaceutical Ingredient Manufacturing FacilityPRNewsWire • 09/29/25
AbbVie Announces UK Pricing Strategy for ELAHERE® (mirvetuximab soravtansine-gynx)PRNewsWire • 09/29/25